Try Alerts Free   |   Login

CRBU Price Correlated With Financials For Caribou Biosciences

Free historical financial statements for Caribou Biosciences Inc.. See how revenue, income, cash flow, and balance sheet financials have changed over 4 quarters since 2021. Compare with CRBU stock chart to see long term trends.

CRBU Stock Compared to Quarterly

CRBU Income Statement

Revenue, Net:2664000
Revenue Per Share:0.0439
Selling, General & Admin Expense:9593000
Research & Development Expense:13924000
Total Operating Expenses:23517000
Operating Income:-20853000
Income Taxes:0
Net Income:-19088000
Earnings Per Share, Basic:-0.32
Shares Outstanding, Basic Avg:60705391

CRBU Cash Flow

Operating Activities Net Income:
Depreciation, Depletion & Amortization:308000
Change in Accounts Receiveable:-779000
Net Cash from Operations:-21673000
Net Cash from Operations Per Share:-0.357
Net Cash from Financing Activities:990000
Property, Plant & Equipment Purchases:723000
Net Cash from Investing Activities:-72107000
Net Change in Cash & Equivalents:-92790000

CRBU Balance Sheet

Cash and Cash Equivalents:390800000
Short-Term Investments:206101000
Accounts Receivable, Net:374000
Total Current Assets:368010000
Property, Plant & Equipment, Net:6016000
Total Assets:445997000
Accounts Payable:1814000
Total Short-Term Liabilities:26667000
Total Liabilities:74200000

Data imported from Caribou Biosciences Inc. SEC filings. Check original filings before making any investment decision.